rs6811856
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_173660.5(DOK7):āc.1113A>Cā(p.Ser371=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.214 in 1,579,746 control chromosomes in the GnomAD database, including 40,280 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.19 ( 3574 hom., cov: 34)
Exomes š: 0.22 ( 36706 hom. )
Consequence
DOK7
NM_173660.5 synonymous
NM_173660.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.44
Genes affected
DOK7 (HGNC:26594): (docking protein 7) The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 4-3493099-A-C is Benign according to our data. Variant chr4-3493099-A-C is described in ClinVar as [Benign]. Clinvar id is 128904.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-3493099-A-C is described in Lovd as [Benign]. Variant chr4-3493099-A-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-4.44 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.497 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOK7 | NM_173660.5 | c.1113A>C | p.Ser371= | synonymous_variant | 7/7 | ENST00000340083.6 | NP_775931.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOK7 | ENST00000340083.6 | c.1113A>C | p.Ser371= | synonymous_variant | 7/7 | 1 | NM_173660.5 | ENSP00000344432 | P1 | |
DOK7 | ENST00000643608.1 | c.681A>C | p.Ser227= | synonymous_variant | 5/8 | ENSP00000495701 | ||||
DOK7 | ENST00000515886.5 | c.183A>C | p.Ser61= | synonymous_variant | 4/4 | 2 | ENSP00000492194 | |||
DOK7 | ENST00000507039.5 | c.*334A>C | 3_prime_UTR_variant | 7/7 | 2 | ENSP00000423614 |
Frequencies
GnomAD3 genomes AF: 0.188 AC: 28587AN: 152040Hom.: 3579 Cov.: 34
GnomAD3 genomes
AF:
AC:
28587
AN:
152040
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.224 AC: 42420AN: 189222Hom.: 5618 AF XY: 0.227 AC XY: 23580AN XY: 104016
GnomAD3 exomes
AF:
AC:
42420
AN:
189222
Hom.:
AF XY:
AC XY:
23580
AN XY:
104016
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.217 AC: 309943AN: 1427588Hom.: 36706 Cov.: 110 AF XY: 0.217 AC XY: 154015AN XY: 708228
GnomAD4 exome
AF:
AC:
309943
AN:
1427588
Hom.:
Cov.:
110
AF XY:
AC XY:
154015
AN XY:
708228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.188 AC: 28585AN: 152158Hom.: 3574 Cov.: 34 AF XY: 0.195 AC XY: 14505AN XY: 74388
GnomAD4 genome
AF:
AC:
28585
AN:
152158
Hom.:
Cov.:
34
AF XY:
AC XY:
14505
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1273
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 05, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 21, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 15, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Fetal akinesia deformation sequence 1;C1850792:Congenital myasthenic syndrome 10 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at